Mitochondrial dysfunction and oxidative stress in insulin resistance
Milagros Rocha1, Susana Rovira-Llopis, Celia Bañuls
1University Hospital Doctor Peset, Endocrinology Service, Avda Gaspar Aguilar 90, 46017, Valencia, Spain.
Current Pharmaceutical Design
|March 2, 2013
Summary
Mitochondrial dysfunction is increasingly linked to insulin resistance and diabetes. This review explores how insulin resistance impacts mitochondria and discusses therapeutic strategies targeting mitochondrial function.
Area of Science:
- Biochemistry
- Metabolism
- Cell Biology
Background:
- Mitochondrial dysfunction is implicated in insulin resistance, type 2 diabetes, and related complications.
- Understanding the interplay between insulin resistance and mitochondrial health is crucial for developing effective treatments.
Purpose of the Study:
- To review the effects of insulin resistance on mitochondrial function across various tissues.
- To examine the pathogenesis of insulin resistance through a mitochondrial lens.
- To explore potential therapeutic strategies targeting mitochondrial function in insulin resistance.
Main Methods:
- Literature review of studies investigating mitochondrial function in insulin resistance.
- Analysis of the role of mitochondria in the development of insulin resistance.
- Evaluation of therapeutic interventions aimed at modulating mitochondrial function.
Main Results:
- Insulin resistance significantly impacts mitochondrial structure and function in key metabolic tissues.
- Mitochondrial pathways are central to the pathogenesis of insulin resistance.
- Therapeutic strategies targeting mitochondria show promise in ameliorating insulin resistance.
Conclusions:
- Mitochondrial dysfunction is a key contributor to insulin resistance and its complications.
- Modulating mitochondrial function presents a viable therapeutic avenue for managing insulin resistance.
- Targeted antioxidant therapies, including mitochondria-specific approaches, warrant further investigation.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...